Onelife Capital Advisors Limited

Financial Services — Capital Markets · NSE

₹50.49+₹0.03 (+0.06%)

DalalBaazaar Score

72 / 100

🟢 Good

Verdict

NEUTRAL

Risk

High

Driven by negative free cash flow, the company is currently loss-making, micro-cap size, which brings thin liquidity.

In simple words: The company is currently losing money, with both sales and profits growing well. Cash generation is currently the main factor to watch.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 7:46 pm

Understanding the Business

Company site ↗

The 60-second version of Onelife Capital Advisors Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

Onelife Capital Advisors Limited, together with its subsidiaries, provides advisory services to corporates, high net worth individuals, and family offices in India. It operates through Advisory Services, Broking Services, Trading Services, and Other Business segments.

IndustryCapital Markets

SectorFinancial Services

Employees46

Annual revenue₹5 Cr

How does it make money?

Turns over ₹5 Cr a year. Of every ₹100 of sales, about ₹109 reaches shareholders as profit, with ₹217 left at the operating level before interest, tax and depreciation. Each of its 46 employees supports ₹10.7 lakh of revenue a year, the signature of a people-led business.

Revenue / employee₹10.7 lakh

Who are its competitors?

The closest listed comparisons in its industry are BAJAJ FINANCE LIMITED, HDFC LIFE INS CO LTD, SBI LIFE INSURANCE CO LTD. These are the companies its valuation and returns are measured against elsewhere in this report.

Compared side by side in Peers ↓

What is its competitive advantage?Not assessable from these ratios

For a lender, returns on capital are shaped by leverage and funding cost rather than by pricing power, so the usual financial signature of an advantage does not apply. Judge this one on deposit franchise, cost of funds and asset quality — none of which are in this data.

Peer median ROE13.7%

What has been driving growth?

Profit has moved mainly because margins changed, not because the business sold much more. Over 3 years revenue moved +53% while net margin moved -241% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect+53%

Margin effect-241%

DalalBaazaar Score

72/ 100

Good

Weighted across six categories. Every point is explained below.

✗ No meaningful P/E — the company is lossmaking

Quality vs. Valuation

Company Quality

84/ 100

Excellent

How good the business is, ignoring the share price entirely.

Valuation

31/ 100

Expensive

What you are being asked to pay, ignoring how good the business is.

A good business, but the price already reflects that. The quality is real; the question is whether you are overpaying for it today.

vs. its own history

Not enough price and earnings history

vs. sector peers

Not enough peers with a usable P/E

vs. generic bands

N/A

No P/E — the company is lossmaking

EV/EBITDA

18.9x

PEG

—

What's Good / What's Bad

🟢 What's Going Well3

Margins are improving
EBITDA margin is up from -28.9% to 216.6% over 3 years.
Return on equity is rising
ROE has improved from -3.0% to 7.4%.
Return on capital is rising
ROCE has improved from -1.1% to 9.8%.

🔴 What Needs Attention0

Nothing stands out as clearly deteriorating on the years of data available.

Red Flags

1 item require attention · 1 watch

🟡Shareholders have been dilutedOwnership
Shares outstanding are up 162% over 3 years — each existing share owns a smaller slice of the company.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Margin expansion has further to run
EBITDA margin has risen from -28.9% to 216.6%. If that holds, profit compounds faster than sales and today's multiple looks cheaper in hindsight than it does now.

🔴 Bear CaseWhat could go wrong?

Earnings are hard to forecast
Profit has swung sharply from year to year, so any single year — good or bad — is a weak guide to the next. Cyclical earnings deserve lower multiples for that reason.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1Revenue growth stays above 11% a year✓ 15.3% CAGR
Latest reported year was 320.4%. The bar is set below the established compounding rate, so ordinary variation does not trip it.
2EBITDA margin holds above 215%✓ 216.6%
Two points below today's level — enough room for noise, tight enough to catch real compression.
3Return on equity stays above 8%✗ 7.4%
For a lender this is the cleanest single read on whether the book is being grown profitably.
4Interest cover stays above 3x✓ 3.0x
How much operating profit can fall before interest stops being comfortably covered.

Investment Checklist

7 / 11 checks passed

✗ Strong return on equity (ROE ≥ 15%)
✗ Strong return on capital employed (ROCE ≥ 15%)
✓ Healthy net margin (≥ 10%)
✗ Generates positive free cash flow
✓ Manageable leverage (Debt/Equity < 1.0)
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✓ Revenue growing year-over-year
✓ Profit growing year-over-year
✓ Not trading at an extreme valuation (P/E < 40x)
✗ Not buying right at the 52-week high
✓ Short-term technical trend isn't bearish

Price history

Quick Metrics

3 good · 4 neutral · 4 weak

Market Cap

₹189 Cr

Micro Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

Not meaningful

Loss-making

Earnings are negative, so a P/E multiple can't be read here

P/B Ratio

2.46x

Fair

Moderate premium to the company's book value

EPS (TTM)

₹-0.26

Loss-making

Negative earnings per share — the business is losing money

ROE

7.4%

Weak

Weak capital efficiency

ROCE

9.8%

Moderate

Moderate return on the capital in the business

Debt/Equity

0.42x

Low

Conservative leverage

Revenue Growth (YoY)

320.4%

Healthy

Healthy top-line growth

Profit Growth (YoY)

204.3%

Healthy

Profits growing at a healthy clip

Dividend Yield

0.02%

Modest

Small cash return — most of the return has to come from the price

Free Cash Flow

-₹38 Cr

Cash burning

Spending more cash than the operations bring in

More Metrics

Operating Margin

59.6%

Good

Healthy core-business profitability

Net Margin

25.8%

Good

Strong bottom-line conversion

Current Ratio

1.29

Comfortable

Healthy short-term liquidity

Beta (vs Nifty)

0.61

Defensive

Steadier than the market

52W Range Position

95%

Near high

Near its 52-week high

Technical Snapshot

SMA 20 / SMA 50

42.8 / 36.7

Bullish alignment (short > long)

Price vs SMA 200

Above

Long-term uptrend

RSI (14)

98.2

Overbought zone

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹3 Cr	₹15 Cr	₹7 Cr	₹5 Cr	+15.3%
EBITDA	-₹1 Cr	₹17 Cr	-₹15 Cr	₹11 Cr	—
EBITDA Margin	-28.9%	111.5%	-210.7%	216.6%	—
PAT (Net Profit)	-₹2 Cr	₹0 Cr	-₹5 Cr	₹5 Cr	—
EPS	₹-1.74	₹0.44	₹-3.42	₹3.58	—
ROE	-3.0%	0.8%	-14.8%	7.4%	—
ROCE	-1.1%	10.7%	-1.1%	9.8%	—
Total Debt	₹13 Cr	₹27 Cr	₹23 Cr	₹31 Cr	+33.3%
Free Cash Flow	₹12 Cr	-₹9 Cr	₹36 Cr	-₹38 Cr	—

🟢 Revenue has grown at 15.3% a year over 3 years.

🟢 EBITDA has turned positive, from -₹1 Cr to ₹11 Cr.

🟢 EBITDA Margin has risen from -28.9% to 216.6% over 3 years (+245.5 pts).

🟢 PAT (Net Profit) has turned positive, from -₹2 Cr to ₹5 Cr.

🟢 EPS has turned positive, from ₹-1.74 to ₹3.58.

🟢 ROE has risen from -3.0% to 7.4% over 3 years (+10.4 pts).

🟢 ROCE has risen from -1.1% to 9.8% over 3 years (+11.0 pts).

🔴 Total Debt has grown at 33.3% a year over 3 years.

🔴 Free Cash Flow has turned negative, from ₹12 Cr to -₹38 Cr.

Balance Sheet & Cash Flow — FY2026

Total Assets

₹176 Cr

Total Liabilities

₹102 Cr

Cash & Equivalents

₹19 Cr

Operating Cash Flow

-₹36 Cr

Capex

-₹2 Cr

Shareholding (proxy)

Institutional Holding

0.0%

Insider Holding

61.9%

Corporate Actions

Dividend Rate

₹0.01

Ex-Dividend Date

22 Sept 2026

Peer Comparison

Company	P/E	ROE
BAJAJ FINANCE LIMITED	30.2x	17.8%
HDFC LIFE INS CO LTD	58.4x	11.3%
SBI LIFE INSURANCE CO LTD	63.9x	13.7%

Recent News

6 general

Onelife Capital Advisors Ltd is Rated Hold

MarketsMojo, 16 Oct

Onelife Capital Advisors (ONELIFECAP.NS) Holds Above ₹50 With a Modest 0.28% Gain - OBV Breakout

https://www.siam.in/, 14 Oct

Onelife Capital Advisors Ltd Locks at Upper Circuit With 5% Gain Amid Delivery Drop and Thin Liquidity

MarketsMojo, 16 Oct

Onelife Capital Advisors Ltd. Financials – Balance Sheet, Profit & Loss, Cash Flow

Value Research, 04 Sept

Onelife Capital Advisors 52 Week High Streak: 4 Sessions

Univest, 09 Oct

Onelife Capital acquires 16 lakh Swojas Foods shares, disposes warrants

scanx.trade, 26 Aug

Watch Items

Trading very close to its 52-week high — momentum-driven entries here carry more mean-reversion risk.
This is a financial-sector business: borrowing is its raw material, not leverage in the usual sense. Debt/Equity and ROCE here aren't comparable to a manufacturer's — read them alongside NIM, GNPA and capital adequacy from the company's own disclosures.
Cross-check against the company's latest quarterly filing / investor presentation before acting.
RSI is in overbought territory — momentum entries here carry more short-term pullback risk.

DalalBaazaar Thesis

StrongBusiness Quality · Financial Health · Growth · Profitability

WeakValuation · Risk

Points for each in the Score ↑

Good business, demanding price

The quality is real and the price already reflects it. Buying here is a bet that the business keeps compounding for long enough to grow into the multiple — which good businesses often do, but it removes the margin for error that a lower price would have given you.

1 of 4 tripwires tripped — Return on equity stays above 8% · see Key things to watch ↑